ACTIVE

PHARMA AND CCS CONSULTING

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result94,2 k €+27,8 %over 1 year
Gross margin148,7 k €+26,2 %over 1 year
Equity412,7 k €+29,4 %over 1 year

Identity

Source · BCE/KBO

PHARMA AND CCS CONSULTING is a Private limited company incorporated in 2021. Its main activity is: Management consultancy activities. Its registered office is in Chaudfontaine.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0772.858.683
Incorporation
25/08/2021
Legal form
Private limited company
Registered office
Rue Albert et Louis Curvers 50
4053 Chaudfontaine · WallonieSee on map
Contributed capital
5 000,00 €
Latest accounts
31/12/2025
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin148,7 k €117,8 k €84 k €287,2 k €
EBITDA147,1 k €116,6 k €82,8 k €284,9 k €
Operating result136,2 k €105,5 k €71,8 k €275,8 k €
Net result94,2 k €73,7 k €50,5 k €189,6 k €
Balance sheet
Equity412,7 k €318,9 k €245,1 k €194,6 k €
Total assets456,3 k €347,7 k €263,5 k €230 k €
Cash433,8 k €302,5 k €232,1 k €163,6 k €
Debts42,4 k €28,3 k €15,3 k €34,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 2 ended

Active mandates

Brigitte JEANGETTE

Director · since 25 août 2021

Active
Eric CLAESSENS

Director · since 25 août 2021

Active

Ended mandates

Brigitte JEANGETTE

Director

Ended
Eric CLAESSENS

Director

Ended

Full financial information

Source · NBB
2025202420232022
Type of accountMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202325/08/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/2022
Length of the financial year12 months12 months12 months17 months
Filing date30/06/202615/07/202531/07/202425/07/2023
General meeting22/06/202630/06/202524/06/202426/06/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202522/06/202630/06/2026FrenchPDF
Micro model31/12/202430/06/202515/07/2025FrenchPDF
Micro model31/12/202324/06/202431/07/2024FrenchPDF
Micro model31/12/202226/06/202325/07/2023FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 2 ended

Active mandates

Brigitte JEANGETTE

Director · since 25 août 2021

Active
Eric CLAESSENS

Director · since 25 août 2021

Active

Ended mandates

Brigitte JEANGETTE

Director

Ended
Eric CLAESSENS

Director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other27/08/2021
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202594,2 k €↑
  2. 2024
    Annual accounts 202473,7 k €↑
  3. 2023
    Annual accounts 202350,5 k €↓
  4. 2022
    Annual accounts 2022189,6 k €
  5. 25/08/2021
    IncorporationPrivate limited company